BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26907188)

  • 21. The identification of atypical reserve cells in smears of patients with premalignant and malignant changes in the squamous and glandular epithelium of the uterine cervix.
    Beyer-Boon ME; Verdonk GW
    Acta Cytol; 1978; 22(5):305-11. PubMed ID: 281835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus triage for young women with atypical squamous cells of undetermined significance.
    Wright JD; Rader JS; Davila R; Powell MA; Mutch DG; Gao F; Gibb RK
    Obstet Gynecol; 2006 Apr; 107(4):822-9. PubMed ID: 16582118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the ThinPrep Pap test in clinical practice. A seven-month, 16,314-case experience in northern Vermont.
    Papillo JL; Zarka MA; St John TL
    Acta Cytol; 1998; 42(1):203-8. PubMed ID: 9479341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Underlying histopathology of HIV-infected women with squamous cell abnormalities on cervical cytology.
    Suwankanta N; Kietpeerakool C; Srisomboon J; Khunamornpong S; Siriaunkgul S
    Asian Pac J Cancer Prev; 2008; 9(3):441-4. PubMed ID: 18990018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cytohistologic study of atypical glandular cells detected in cervical smears during cervical screening tests in Iran.
    Mood NI; Eftekhar Z; Haratian A; Saeedi L; Rahimi-Moghaddam P; Yarandi F
    Int J Gynecol Cancer; 2006; 16(1):257-61. PubMed ID: 16445641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relevance of random biopsy at the transformation zone when colposcopy is negative.
    Huh WK; Sideri M; Stoler M; Zhang G; Feldman R; Behrens CM
    Obstet Gynecol; 2014 Oct; 124(4):670-678. PubMed ID: 25198268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical staining for cytology-based cervical cancer screening.
    Chang WH; Chou FW; Wang PH
    Taiwan J Obstet Gynecol; 2024 May; 63(3):285-287. PubMed ID: 38802187
    [No Abstract]   [Full Text] [Related]  

  • 28. Dysplasia and early neoplasia of the uterine cervix. A review.
    Briggs RM
    Obstet Gynecol Surv; 1979 Jan; 34(1):70-99. PubMed ID: 375145
    [No Abstract]   [Full Text] [Related]  

  • 29. Cervical intraepithelial neoplasia (dysplasia and carcinoma in situ) and early invasive cervical carcinoma.
    Nelson JH; Averette HE; Richart RM
    CA Cancer J Clin; 1989; 39(3):157-78. PubMed ID: 2496898
    [No Abstract]   [Full Text] [Related]  

  • 30. Pap smears with reactive cellular changes: a prospective study.
    Ding DC; Hsu S; Chen SS; Hsu YH
    J Reprod Med; 2007 Oct; 52(10):938-40. PubMed ID: 17977169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunoexpression of heparanase 2 in normal epithelium, intraepithelial, and invasive squamous neoplasia of the cervix.
    Marques RM; Focchi GR; Theodoro TR; Castelo A; Pinhal MA; Nicolau SM
    J Low Genit Tract Dis; 2012 Jul; 16(3):256-62. PubMed ID: 22453758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
    Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
    Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pregnancy related cervical cytological changes and clinical management].
    Ma L; Bian ML; Liu J; Wang XH; Pang CH; Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):84-7. PubMed ID: 21426763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocervical component in conventional cervical smears: influence on detection of squamous cytologic abnormalities.
    Ribeiro AA; Santos Sdo C; de Souza e Silva SR; Nascimento MA; Fonsechi-Carvasan GA; Carneiro MA; Rabelo-Santos M; Rabelo-Santos SH
    Diagn Cytopathol; 2007 Apr; 35(4):209-12. PubMed ID: 17351943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of cervical screening results in a population at normal risk.
    Karabulut A; Alan T; Ali Ekiz M; Iritaş A; Kesen Z; Yahşi S
    Int J Gynaecol Obstet; 2010 Jul; 110(1):40-2. PubMed ID: 20362986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion.
    Nasser SM; Cibas ES; Crum CP; Faquin WC
    Cancer; 2003 Oct; 99(5):272-6. PubMed ID: 14579293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytological classifications of vaginal smears. Current concepts of complex cytodiagnosis].
    Kasabova M
    Akush Ginekol (Sofiia); 1984; 23(4):357-64. PubMed ID: 6385754
    [No Abstract]   [Full Text] [Related]  

  • 38. State of the science: cervical cancer screening in transition.
    Dinkelspiel H; Kinney W
    Gynecol Oncol; 2014 Jun; 133(3):389-93. PubMed ID: 24878390
    [No Abstract]   [Full Text] [Related]  

  • 39. Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in China.
    Pan QJ; Hu SY; Zhang X; Ci PW; Zhang WH; Guo HQ; Cao J; Zhao FH; Lytwyn A; Qiao YL
    Cancer Cytopathol; 2013 Sep; 121(9):473-82. PubMed ID: 23907807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of the Papanicolaou test in the detection of high-grade cervical lesions.
    Repše-Fokter A
    Int J Gynaecol Obstet; 2011 Jan; 112(1):65-6. PubMed ID: 21056413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.